Tarsus Pharmaceuticals (TARS) Earnings Date, Estimates & Call Transcripts $58.58 +0.42 (+0.72%) Closing price 04:00 PM EasternExtended Trading$58.58 +0.01 (+0.01%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tarsus Pharmaceuticals Earnings Summary Tarsus Pharmaceuticals released Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.48, which missed analysts' consensus estimates of -$0.33 by $0.15. Quarterly revenue was reported to be $102.66 million, above analysts' expectations of $95.81 million. With a trailing EPS of -$2.33, Tarsus Pharmaceuticals' earnings are expected to grow next year, from ($3.17) to ($1.44) per share. Upcoming Q3 Earnings DateNov. 12After Market ClosesEstimatedConsensus EPS (Aug. 6) -$0.33 Actual EPS (Aug. 6) -$0.48 Missed By -$0.15 Actual Revenue (Aug. 6) $102.66MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckTARS Upcoming EarningsTarsus Pharmaceuticals' next earnings date is estimated for Wednesday, November 12, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Tarsus Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tarsus Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTARS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TARS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tarsus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.82-$0.78-$0.80Q2 20253-$0.48-$0.41-$0.46Q3 20253-$0.38-$0.31-$0.34Q4 20253-$0.14$0.02-$0.08 FY 2025 12 -$1.82 -$1.48 -$1.67 Q1 20261-$0.05-$0.05-$0.05Q2 20261$0.23$0.23$0.23Q3 20261$0.40$0.40$0.40Q4 20261$0.81$0.81$0.81 Tarsus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)--------8/6/2025Q2 2025-$0.33-$0.48 -$0.15-$0.48$95.81M$102.66M5/1/2025Q1 2025-$0.69-$0.64+$0.05-$0.64$72.50M$78.34M2/25/2025Q4 2024-$0.68-$0.60+$0.08-$0.60$58.80M$66.41M8/8/2024Q2 2024-$0.98-$0.88+$0.10-$0.88$31.30M$40.81M5/8/2024Q1 2024-$1.15-$1.01+$0.14-$1.01$17.94M$27.61M2/27/2024Q4 2023-$1.37-$1.31+$0.06-$1.31$4.63M$13.08M11/9/2023Q3 2023-$1.40-$1.28+$0.12-$1.28$0.72M$1.87M Tarsus Pharmaceuticals Earnings - Frequently Asked Questions When is Tarsus Pharmaceuticals' earnings date? Tarsus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on TARS's earnings history. Did Tarsus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Tarsus Pharmaceuticals (NASDAQ:TARS) missed the analysts' consensus estimate of ($0.33) by $0.15 with a reported earnings per share (EPS) of ($0.48). Learn more on analysts' earnings estimate vs. TARS's actual earnings. How can I listen to Tarsus Pharmaceuticals' earnings conference call? The conference call for Tarsus Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Tarsus Pharmaceuticals' conference call transcript? The conference call transcript for Tarsus Pharmaceuticals' latest earnings report can be read online. Read Transcript How much revenue does Tarsus Pharmaceuticals generate each year? Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded annual revenue of $295.52 million. How much profit does Tarsus Pharmaceuticals generate each year? Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded net income of -$115.55 million. TARS has generated -$2.33 earnings per share over the last four quarters. What is Tarsus Pharmaceuticals' EPS forecast for next year? Tarsus Pharmaceuticals' earnings are expected to grow from ($3.17) per share to ($1.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies BridgeBio Pharma Earnings Date Elanco Animal Health Earnings Date Verona Pharma PLC American Depositary Share Earnings Date Roivant Sciences Earnings Date Revolution Medicines Earnings Date Rhythm Pharmaceuticals Earnings Date Legend Biotech Earnings Date Avidity Biosciences Earnings Date Axsome Therapeutics Earnings Date Nuvalent Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:TARS) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access